Trials / Unknown
UnknownNCT04232605
Investigation of Vasodilation and Intensity of Headache Triggered by Glucagon Like Peptide-1 in Humans
Investigation of Vasodilation and Intensity of Headache Triggered by Glucagon-like Peptide-1 in Healthy Volunteers and Migraine Patients
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 43 (estimated)
- Sponsor
- Danish Headache Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Studying glucagon-like peptide-1 (GLP-1) induced vasodilatory effects on extra - and intracerebral arteries and headache in healthy volunteers and migraine patients without aura.
Detailed description
The purpose of this study is to examine the association between vasodilation and intensity of headache triggered by glucagon-like peptide 1 (GLP-1) in healthy volunteers and migraine patients without aura.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | GLP-1 peptide | Receive intravenous infusion of GLP-1. The dosage will be determined after a dose finding pilot study. |
| OTHER | Placebo | Receive intravenous infusion saline |
Timeline
- Start date
- 2020-01-09
- Primary completion
- 2021-12-31
- Completion
- 2022-01-01
- First posted
- 2020-01-18
- Last updated
- 2020-01-18
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT04232605. Inclusion in this directory is not an endorsement.